CaoBSunXYZhangCBYanJJZhaoQQYangSYet al
Regulatory challenges persist, particularly regarding concentration limits and regional compliance variations
6h, i and Supplementary Fig
however, this is FDA staff's proposed position going into the meeting, not a final action, and the committee's discussion, any vote, and FDA's ultimate decision are still pending, so the outcome of the review is not yet known
But the time to see research results varies
Lactate has long been considered a waste by-product of cell metabolism, and it accumulates at sites of high glycolytic activity, such as tumor surroundings or inflamed tissue areas